Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: Implications for tumor vaccines with melanoma-associated antigens

International Journal of Cancer

Volumn 66, Issue 2, 1996, Pages 162-169

  Jäeger, Elke ^a   Bernhard, Helga ^b   Romero, Pedro ^c   Ringhoffer, Mark ^a   Arand, Michael ^b   Karbach, Julia ^a   Ilsemann, Christiane ^d   Hagedorn, Manfred ^d   Knuth, Alexander ^a,e  

^a KRANKENHAUS NORDWEST   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d KLINIKUM DARMSTADT   (Germany)

^e Medizinische Klinik I   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; SYNTHETIC PEPTIDE; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; CANCER REGRESSION; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG EFFECT; FEMALE; HUMAN; MALE; MELANOMA; PRIORITY JOURNAL; VACCINATION;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; CELLS, CULTURED; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; INJECTIONS, INTRADERMAL; MALE; MELANOMA; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES;

EID: 0029997742     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960410)66:2<162::AID-IJC4>3.0.CO;2-0     Document Type: Article

References (29)

1. BARKER, A.B., SCHREURS, M.W.J., DE BOER, A.J., KAWAKAMI, Y., ROSENBERG, S.A., ADEMA, G.J. and FIGDOR, C.G., Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumorinfiltrating lymphocytes. J exp. Med., 179, 1005-1009 (1994).
2. BAKKER, A.B., SCHREURS, M.W.J., TAFAZZUL, G., DE BOER, A.J., KAWAKAMI, Y., ADEMA, G.J. and FIGDOR, C.G., Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1 restricted antimelanoma CTL line. Int. J. Cancer 62, 97-102 (1995).
3. BERNHARD, H., KARBACH, J., WÖLFEL, T., BUSCH, P., STÖRKEL, S., STÖCKLE, M., WOLFEL, C., SELIGER, B., HUBER, C., MEYER ZUM BÜSCHENFELDE, K.-H. and KNUTH, A., Cellular immune response to human renal cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T lymphocytes. Int. J. Cancer, 59, 837-842 (1994).
4. BODMER, H., OGG, G., GOTCH, F. and McMICHAEL, A., Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes. Nature (Lond.), 342, 443-446 (1989).
5. BOON, T., GAJEWSKI, T.F. and COULIE, P., From defined human tumor antigens to effective immunization? Immunol. Today, 16, 334-336 (1995).
6. BRICHARD, V., VAN PEL, A., WÖLFEL, T., WOLFEL, C., DE PLAEN, E., LETHE, B., COULIE, P. and BOON, T., The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. exp. Med., 178, 489-495 (1993).
7. BRUNDA, M.J., LUISTRO, L., WARRIER, R.R., WRIOHT, R.B., HUBBARD, B.R., MURPHY, M., WOLF, S.F. and GATELY, M.K., Antitumor and antimetastatic activity of interleukin-12 against murine tumors. J. exp. Med., 178, 1223-1230 (1993).
8. COULIE, P.G., BRICHARD, V., VAN PEL, A., WÖLFEL, T., SCHNEIDER, J . TRAVERSARI, C., MATTEI, S., DE PLAEN, E., LURQUIN, C., SZIKORA, J.-P., RENAULD, J.-C. and BOON, T., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. exp. Med., 180, 35-42 (1994).
9. Cox, A.L., SKIPPER, J., CHEN, Y., HENDERSON, R.A., DARROW, T.L , SHABANOWITZ, J., ENGELHARD, V.H., HUNT, D.F. and SLINGLUFF, C.L.S., Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science, 264, 716-719 (1994).
10. DRANOFF, G., JAFFEE, E., LAZENBRY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JECKSON, V., HAMADA, H., PARDOLL, D. and MULLIGAN, R., Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. nat. Acad. Sci. (Wash.), 90, 3539-3543 (1993).
11. FYNAN, E.F., WEBSTER, R.G., FULLER, D.H., HAYNES, J.R., SANTORO, J.C. and ROBINSON, H.L., DNA vaccines: protective immunizations by parenteral, mucosal and gene-gun inoculations. Proc. nat. Acad. Sci. (Wash.), 90, 11478-11482 (1993).
12. KANG, X.Q., KAWAKAMI, Y., EL-GAMIL, M., WANG, R., SAKAGUCHI, K., YANNELLI, J.R., APPELLA, E. and ROSENBERG, S.A., Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumorinfiltrating lymphocytes. J. Immunol., 155, 1343-1348 (1995).
13. KAWAKAMI, Y., ELIYAHU, S., DELGADO, C.H., ROBBINS, P.P., RIVOLTINI, L., TOPALIAN, S.L., MIKI, T. and ROSENBERG, S.A., Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. nat. Acad. Sci. (Wash.), 91, 3525-3529 (1994a).
14. KAWAKAMI, Y., ELIYAHU, S., DELGADO, C.H., ROBBINS, P.F., SAKAGUCHI, K., APPELLA, E., YANNELLI, J.R., ADEMA, G.J., MIKI, T. and ROSENBERG, S.A., Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. nat. Acad. Sci. (Wash.), 91, 6458-6462 (19946).
15. KAWAKAMI, Y., ELIYAHU, S., JENNINGS, C., SAKAGUCHI, K., KANG, X.Q., SOUTHWOOD, S., ROBBINS, P.P., SETTE, A., APPELLA, E. and ROSENBERG, S.A., Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating lymphocytes associated with in vivo tumor regression. J. Immunol., 154, 3961-3968 (1995).
16. KNUTH, A., WÖLFEL, T. and MEYER ZUM BÜSCHENFELDE, K.-H., T cell responses to human malignant tumours. Cancer Surv., 13, 39-52 (1992).
17. MATZINGER, P., Tolerance, danger, and the extended family. Ann. Rev. Immunol., 12, 991-1045 (1994).
18. NANDA, N.K. and SERCARZ, E.E., Induction of anti-self-immunity to cure cancer. Cell, 82, 13-17 (1995).
19. NOGUCHI, Y., RICHARDS, E.C., CHEN, Y.T. and OLD, L.J., Influence of interleukin-12 on p53 peptide vaccination against established Meth A sarcoma. Proc. nat. Acad. Sci. (Wash ), 92, 2219-2223 (1995).
20. RIVOLTINI, L., KAWAKAMI, Y., SAKAGUCHI, K., SOUTHWOOD, S., SETTE, A., ROBBINS, P.F., MARINCOLA, F.M., SALGALLER, M.L., YANNELLI, J.R., APPELLA, E. and ROSENBERG, S.A., Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol., 154, 2257-2265 (1995).
21. ROBBINS, P.P., EL-GAMIL, M., KAWAKAMI, Y. and ROSENBERG, S.A., Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res., 54, 3124-3126 (1994).
22. SALLUSTO, F. and LANZAVECCHIA, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor alpha. J. exp. Med., 179, 1109-1118 (1994).
23. SLOAN-LANCASTER, J. and ALLEN, P.M., Significance of T-cell stimulation by altered peptide ligands in T cell biology. Curr. Opin. Immunol., 7, 103-109 (1995).
24. STINGL, G. and BERGSTRESSER, P.R., Dendritic cells: a major story unfolds. Immunol. Today, 16, 330-333 (1995).
25. VAN DER BRUGGEN, P., TRAVERSARI, C., CHOMEZ, P., LURQUIN, C., DE PLAEN, E., VAN DEN EYNDE, B., KNUTH, A. and BOON, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254, 1643-1647 (1991).
26. VISSEREN, M.J.W., VAN ELSAS, A., VAN DER VOORT, E.I.H., RESSING, M.E., KAST, W.M., SCHRIER, P.I. and MELIEF, C.J.M., CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells. J Immunol., 154, 3991-3998 (1995).
27. WANG, R.-F., ROBBINS, P.F., KAWAKAMI, Y., KANG, X.-Q. and ROSENBERG, S.A., Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J. exp. Med., 181, 799-804 (1995).
28. WOLFEL, T., SCHNEIDER, J., MEYER ZUM BÜSCHENFELDE, K.-H., RAMMENSEE, H.-G., RÖTZSCHKE, O. and FALK, K., Isolation of naturally processed peptides recognized by cytolytic T lymphocytes (CTL) on human melanoma cells in association with HLA-A2.1. Int. J. Cancer, 57, 413-418 (1994a).
29. WÖLFEL, T., VAN PEL, A., BRICHARD, V., SCHNEIDER, J., SELIGER, B., MEYER ZUM BÜSCHENFELDE, K.-H. and BOON, T., Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Europ. J. Immunol., 24, 759-764 (1994b).